UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 185

Sortiert nach

The Pentraxins 1975-2018: Serendipity, Diagnostics and Drugs

Frontiers in immunology, 2018-10, Vol.9, p.2382-2382

Pepys, Mark B

2018

Link zum Volltext

Verfügbarkeit prüfen

Amyloidosis

Annual review of medicine, 2006-01, Vol.57 (1), p.223-241

Pepys, Mark B

2006

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component

The New England journal of medicine, 2015-09, Vol.373 (12), p.1106-1114

2015

Link zum Volltext

Verfügbarkeit prüfen

Multinucleated Giant Cells Are Specialized for Complement-Mediated Phagocytosis and Large Target Destruction

Cell reports (Cambridge), 2015-12, Vol.13 (9), p.1937-1948

2015

Link zum Volltext

Verfügbarkeit prüfen

C-reactive protein predicts outcome in COVID-19: is it also a therapeutic target?

European heart journal, 2021-06, Vol.42 (23), p.2280-2283

Pepys, Mark B

2021

Link zum Volltext

Verfügbarkeit prüfen

C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease

The New England journal of medicine, 2004-04, Vol.350 (14), p.1387-1397

2004

Link zum Volltext

Verfügbarkeit prüfen

Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis

Nature communications, 2021-12, Vol.12 (1), p.7112-7112, Article 7112

2021

Link zum Volltext

Verfügbarkeit prüfen

Hereditary Systemic Amyloidosis Due to Asp76Asn Variant β2-Microglobulin

The New England journal of medicine, 2012-06, Vol.366 (24), p.2276-2283

2012

Link zum Volltext

Verfügbarkeit prüfen

Comparative study of the stabilities of synthetic in vitro and natural ex vivo transthyretin amyloid fibrils

The Journal of biological chemistry, 2020-08, Vol.295 (33), p.11379-11387

2020

Link zum Volltext

Verfügbarkeit prüfen

Human plasma fibrinogen is synthesized in the liver

Blood, 2007-03, Vol.109 (5), p.1971-1974

2007

Link zum Volltext

Verfügbarkeit prüfen

Pathogenetic mechanisms of amyloid A amyloidosis

Proceedings of the National Academy of Sciences - PNAS, 2013-10, Vol.110 (40), p.16115-16120

2013

Link zum Volltext

Verfügbarkeit prüfen

Transthyretin amyloidosis: new answers but many questions

Journal of internal medicine, 2021-06, Vol.289 (6), p.933-935

Pepys, Mark B.

2021

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channel

Scientific reports, 2017-03, Vol.7 (1), p.182-7, Article 182

2017

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1

PloS one, 2018-05, Vol.13 (5), p.e0197299

2018

Link zum Volltext

Verfügbarkeit prüfen

Serum amyloid P component accumulates and persists in neurones following traumatic brain injury

Open biology, 2023-12, Vol.13 (12), p.230253-230253

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of alcohol consumption on systemic markers of inflammation

The Lancet (British edition), 2001-03, Vol.357 (9258), p.763-767

2001

Link zum Volltext

Verfügbarkeit prüfen

Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein

The Lancet (British edition), 2001-07, Vol.358 (9275), p.24-29

2001

Link zum Volltext

Verfügbarkeit prüfen

Misdiagnosis of Hereditary Amyloidosis as AL (Primary) Amyloidosis

The New England journal of medicine, 2002-06, Vol.346 (23), p.1786-1791

2002

Link zum Volltext

Verfügbarkeit prüfen

Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy

British journal of haematology, 2003-07, Vol.122 (1), p.78-84

2003

Link zum Volltext

Verfügbarkeit prüfen

Human C-Reactive Protein Increases Cerebral Infarct Size After Middle Cerebral Artery Occlusion in Adult Rats

Journal of cerebral blood flow and metabolism, 2004-11, Vol.24 (11), p.1214-1218

2004

Link zum Volltext

Verfügbarkeit prüfen

Transgenic Human C-Reactive Protein Is Not Proatherogenic in Apolipoprotein E-Deficient Mice

Proceedings of the National Academy of Sciences - PNAS, 2005-06, Vol.102 (23), p.8309-8314

2005

Link zum Volltext

Verfügbarkeit prüfen

Production of C-reactive protein and risk of coronary events in stable and unstable angina

The Lancet (British edition), 1997-02, Vol.349 (9050), p.462-466

1997

Link zum Volltext

Verfügbarkeit prüfen

molecular correlate of clinicopathology in transthyretin amyloidosis

The Journal of pathology, 2009-01, Vol.217 (1), p.1-3

Pepys, Mark B

2009

Link zum Volltext

Verfügbarkeit prüfen

Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences

Circulation (New York, N.Y.), 2004-06, Vol.109 (24), p.3022-3028

2004

Link zum Volltext

Verfügbarkeit prüfen

Complement Factor H Binds to Denatured Rather than to Native Pentameric C-reactive Protein

The Journal of biological chemistry, 2008-11, Vol.283 (45), p.30451-30460

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(174)
Mit Volltextzugriff
(164)

Publikationsform

Artikel
(185)

Sprache

Englisch
(185)
Japanisch
(46)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Pentraxins 1975-2018: Serendipity, Diagnostics and Drugs

Amyloidosis

Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component

Multinucleated Giant Cells Are Specialized for Complement-Mediated Phagocytosis and Large Target Destruction

C-reactive protein predicts outcome in COVID-19: is it also a therapeutic target?

C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease

Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis

Hereditary Systemic Amyloidosis Due to Asp76Asn Variant β2-Microglobulin

Comparative study of the stabilities of synthetic in vitro and natural ex vivo transthyretin amyloid fibrils

Human plasma fibrinogen is synthesized in the liver

Pathogenetic mechanisms of amyloid A amyloidosis

Transthyretin amyloidosis: new answers but many questions

Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channel

Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1

Serum amyloid P component accumulates and persists in neurones following traumatic brain injury

Effect of alcohol consumption on systemic markers of inflammation

Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein

Misdiagnosis of Hereditary Amyloidosis as AL (Primary) Amyloidosis

Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy

Human C-Reactive Protein Increases Cerebral Infarct Size After Middle Cerebral Artery Occlusion in Adult Rats

Transgenic Human C-Reactive Protein Is Not Proatherogenic in Apolipoprotein E-Deficient Mice

Production of C-reactive protein and risk of coronary events in stable and unstable angina

molecular correlate of clinicopathology in transthyretin amyloidosis

Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences

Complement Factor H Binds to Denatured Rather than to Native Pentameric C-reactive Protein

Suchergebnisse filtern